US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 33.900
  • -1.630-4.59%
Close Feb 24 16:00 ET
  • 33.900
  • 0.0000.00%
Post 20:01 ET
13.08BMarket Cap-3.65P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5800
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Brad Miller
  • Chief Information Officer
  • --
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • David M. Rubenstein
  • Director
  • --
  • Abbas Hussain
  • Director
  • --
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
  • Paul Sagan
  • Independent Director
  • 461.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More